RETINAL ANGIOMATOUS PROLIFERATION IN AGE–RELATED MACULAR DEGENERATION
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: It is known that choroidal neovascularization (CNV) in age-related macular degeneration (ARMD) may erode through the retinal pigment epithelium, infiltrate the neurosensory retina, and communicate with the retinal circulation in what has been referred to as a retinal–choroidal anastomosis (RCA). This is extremely common in the end stage of disciform disease. In recent years, the reverse also seems to be possible, as angiomatous proliferation originates from the retina and extends posteriorly into the subretinal space, eventually communicating in some cases with choroidal new vessels. This form of neovascular ARMD, termed retinal angiomatous proliferation (RAP) in this article, can be confused with CNV. PURPOSE: The purpose of this article is 1) to review the clinical and angiographic characteristics of a series of patients with RAP and 2) to propose a theoretical sequence of events that accounts for the neovascularized process. METHODS: In this retrospective clinical and angiographic analysis, 143 eyes with RAP (108 patients) were reviewed and classified based on their vasogenic nature and course. Clinical biomicroscopic examination, fluorescein angiography, and indocyanine green angiography were used to evaluate patients. RESULTS: The results of this series suggest that angiomatous proliferation within the retina is the first manifestation of the vasogenic process in this form of neovascular ARMD. Dilated retinal vessels and pre-, intra-, and subretinal hemorrhages and exudate evolve, surrounding the angiomatous proliferation as the process extends into the deep retina and subretinal space. One or more dilated compensatory retinal vessels perfuse and drain the neovascularization, sometimes forming a retinal–retinal anastomosis. Fluorescein angiography in these patients usually revealed indistinct staining simulating occult CNV. Indocyanine green angiography was useful to make an accurate diagnosis in most cases. It revealed a focal area of intense hyperfluorescence corresponding to the neovascularization ("hot spot") and other characteristic findings. Based on understanding of the nature and progression of the neovascularized process, patients with RAP were classified into three vasogenic stages. Stage I involved proliferation of intraretinal capillaries originating from the deep retinal complex (intraretinal neovascularization [IRN]). Stage II was determined by growth of the retinal vessels into the subretinal space (subretinal neovascularization [SRN]). Stage III occurred when CNV could clearly be determined clinically or angiographically. A vascularized pigment epithelial detachment and RCA were inconsistent features of this stage. CONCLUSIONS: Retinal angiomatous proliferation appears to be a distinct subgroup of neovascular ARMD. It may present in one of three vasogenic stages: IRN, SRN, or CNV. Whereas ICG angiography is helpful in diagnosing RAP and in documenting the stage of the neovascularized process, it is frequently difficult to determine the precise nature and location of the new vessel formation. It is important for clinicians to recognize the vasogenic potential and the associated manifestations of this peculiar form of neovascular ARMD so that a proper diagnosis can be made, and when possible, an appropriate management administered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793
(1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.10.1329 · Cited by 2,192
Adamis, A. P., Miller, J. W., Bernal, M.-T., D'Amico, D. J., Folkman, J., Yeo, T.-K., & Yeo, K.-T. (1994) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)75794-0 · Cited by 1,296
Pierce, E. A., Avery, R. L., Foley, E. D., Aiello, L. P., & Smith, L. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.905 · Cited by 1,027
Stone, J., Itin, A., Alon, T., Pe'er, J., Gnessin, H., Chan-Ling, T., & Keshet, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-07-04738.1995 · Cited by 1,006
Idiopathic Senile Macular Hole: Its Early Stages and Pathogenesis
Gass, J. D. M. (1988) · Archives of Ophthalmology · doi:10.1001/archopht.1988.01060130683026 · Cited by 992
Age-related Macular Degeneration Histopathologic Studies
Green, W. R., & Enger, C. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31466-1 · Cited by 757
Bressler, N. M. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)01237-5 · Cited by 666
Lopez, P. F., Sippy, B. D., Lambert, H. M., Thach, A. B., & Hinton, D. R. (1998) · Retina · doi:10.1097/00006982-199805000-00035 · Cited by 592
Tolentino, M. J., Miller, J. W., Gragoudas, E. S., Jakobiec, F. A., Flynn, E., Chatzstefanou, K., Ferrara, N., & Adamis, A. P. (1996) · Ophthalmology · doi:10.1016/s0161-6420(96)30420-x · Cited by 518
Cited by
Age-related macular degeneration
Fleckenstein, M., Keenan, T. D. L., Guymer, R. H., Chakravarthy, U., Schmitz-Valckenberg, S., Klaver, C. C., Wong, W. T., & Chew, E. Y. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00265-2 · Cited by 978
Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies
Ambati, J., Ambati, B. K., Yoo, S. H., Ianchulev, S., & Adamis, A. P. (2003) · Survey of Ophthalmology · doi:10.1016/s0039-6257(03)00030-4 · Cited by 959
Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data
Spaide, R. F., Jaffe, G. J., Sarraf, D., Freund, K. B., Sadda, S. R., Staurenghi, G., Waheed, N. K., Chakravarthy, U., Rosenfeld, P. J., Holz, F. G., et al. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2019.11.004 · Cited by 824
Self-citationVascular endothelial growth factor in eye disease
Penn, J. S., Madan, A., Caldwell, R. B., Bartoli, M., Caldwell, R. W., & Hartnett, M. E. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.001 · Cited by 762
Bringmann, A., Iandiev, I., Pannicke, T., Wurm, A., Hollborn, M., Wiedemann, P., Osborne, N. N., & Reichenbach, A. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.07.001 · Cited by 761
MICHELS, S., ROSENFELD, P., PULIAFITO, C., MARCUS, E., & VENKATRAMAN, A. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.02.007 · Cited by 664
Schmidt-Erfurth, U., Chong, V., Loewenstein, A., Larsen, M., Souied, E., Schlingemann, R., Eldem, B., Monés, J., Richard, G., & Bandello, F. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2014-305702 · Cited by 639
Molecular pathology of age-related macular degeneration
Ding, X., Patel, M., & Chan, C.-C. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.10.001 · Cited by 582
“…mainly from the retinal circulation in a process that has been called retinal angiomatous proliferations (RAP), also called deep retinal vascular anomalous complex or retinochoroidal anastomosis (Brancato et al., 2002;Donati et al., 2006;Ghazi, 2002;Hunter et al., 2004;Yannuzzi et al., 2001).”
BackgroundMolecular pathogenesis of retinal and choroidal vascular diseases
Campochiaro, P. A. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.06.002 · Cited by 545
Clinical Characteristics of Exudative Age-related Macular Degeneration in Japanese Patients
Maruko, I., Iida, T., Saito, M., Nagayama, D., & Saito, K. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.03.047 · Cited by 544
Self-citationOptical coherence tomography: Imaging of the choroid and beyond
Mrejen, S., & Spaide, R. F. (2013) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2012.12.001 · Cited by 477
Idiopathic Macular Telangiectasia
Yannuzzi, L. A. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.4.450 · Cited by 474
Self-citationSpectral-Domain Optical Coherence Tomography Angiography of Choroidal Neovascularization
de Carlo, T. E., Bonini Filho, M. A., Chin, A. T., Adhi, M., Ferrara, D., Baumal, C. R., Witkin, A. J., Reichel, E., Duker, J. S., & Waheed, N. K. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.01.029 · Cited by 394
Freund, K. B., Zweifel, S. A., & Engelbert, M. (2010) · Retina · doi:10.1097/iae.0b013e3181e7976b · Cited by 386
Self-citationMechanisms of age‐related macular degeneration and therapeutic opportunities
van Lookeren Campagne, M., LeCouter, J., Yaspan, B. L., & Ye, W. (2014) · The Journal of Pathology · doi:10.1002/path.4266 · Cited by 382
“Retinal-to-choroidal anastomoses occur in some eyes of this strain in a process that mimics retinal angiomatous proliferation (RAP) that occurs in approximately 20% of human NVAMD cases [53,54].”
BackgroundAge-Related Macular Degeneration Preferred Practice Pattern®
Flaxel, C. J., Adelman, R. A., Bailey, S. T., Fawzi, A., Lim, J. I., Vemulakonda, G. A., & Ying, G.-S. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2019.09.024 · Cited by 349
Spaide, R. F. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2008.10.005 · Cited by 307
(2000) · CrossRef Listing of Deleted DOIs · doi:10.1016/j.ohc.2006.05.009 · Cited by 299
Mitchell, P., Korobelnik, J.-F., Lanzetta, P., Holz, F. G., Prunte, C., Schmidt-Erfurth, U., Tano, Y., & Wolf, S. (2010) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.159160 · Cited by 295
TYPE 3 NEOVASCULARIZATION: The Expanded Spectrum of Retinal Angiomatous Proliferation
FREUND, K. B., -VAN HO, I., BARBAZETTO, I. A., KOIZUMI, H., LAUD, K., FERRARA, D., MATSUMOTO, Y., SORENSON, J. A., & YANNUZZI, L. (2008) · Retina · doi:10.1097/iae.0b013e3181669504 · Cited by 295
Self-citationSubretinal drusenoid deposits AKA pseudodrusen
Spaide, R. F., Ooto, S., & Curcio, C. A. (2018) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2018.05.005 · Cited by 292
Evaluation of Age-related Macular Degeneration With Optical Coherence Tomography
Keane, P. A., Patel, P. J., Liakopoulos, S., Heussen, F. M., Sadda, S. R., & Tufail, A. (2012) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2012.01.006 · Cited by 280
Fundus autofluorescence and age-related macular degeneration
Spaide, R. F. (2003) · Ophthalmology · doi:10.1016/s0161-6420(02)01756-6 · Cited by 255
Gomi, F., Ohji, M., Sayanagi, K., Sawa, M., Sakaguchi, H., Oshima, Y., Ikuno, Y., & Tano, Y. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.02.031 · Cited by 239
Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature
Shen, J., Frye, M., Lee, B. L., Reinardy, J. L., McClung, J. M., Ding, K., Kojima, M., Xia, H., Seidel, C., Silva, R. L. E., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74527 · Cited by 217
“Subretinal NV occurs in patients with neovascular AMD and can originate either from the choroid (choroidal NV) or from the deep capillary bed of the retina, termed retinal angiomatous proliferation (RAP) (28).”
Reactive nonproliferative gliosis predominates in a chronic mouse model of glaucoma
Inman, D. M., & Horner, P. J. (2007) · Glia · doi:10.1002/glia.20516 · Cited by 204
Pathogenesis of lesions in late age-related macular disease
Holz, F. G., Pauleikhoff, D., Klein, R., & Bird, A. C. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.026 · Cited by 203
On phagocytes and macular degeneration
Guillonneau, X., Eandi, C. M., Paques, M., Sahel, J.-A., Sapieha, P., & Sennlaub, F. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.06.002 · Cited by 185
Subtype lesions of neovascular age-related macular degeneration in Chinese patients
Liu, Y., Wen, F., Huang, S., Luo, G., Yan, H., Sun, Z., & Wu, D. (2007) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-007-0575-8 · Cited by 176
“Yannuzzi et al. [ 13 ] reported the average onset for active neovascular involvement in the fellow eye was 15 months.”
BackgroundArakawa, S., Takahashi, A., Ashikawa, K., Hosono, N., Aoi, T., Yasuda, M., Oshima, Y., Yoshida, S., Enaida, H., Tsuchihashi, T., et al. (2011) · Nature Genetics · doi:10.1038/ng.938 · Cited by 149
Dorrell, M. I., Aguilar, E., Jacobson, R., Yanes, O., Gariano, R., Heckenlively, J., Banin, E., Ramirez, G. A., Gasmi, M., Bird, A., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35977 · Cited by 127
“Another feature common to RAP, MacTel, and the Vldlr –/– retina is that the nonuniformly distributed focal vascular lesions are directly associated with neuronal degeneration separated by relatively normal regions.”
InfluentialHu, W., Jiang, A., Liang, J., Meng, H., Chang, B., Gao, H., & Qiao, X. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0870 · Cited by 117
Mouse models of age-related macular degeneration
Elizabeth Rakoczy, P., Yu, M. J. T., Nusinowitz, S., Chang, B., & Heckenlively, J. R. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.10.012 · Cited by 107
Indaram, M., Ma, W., Zhao, L., Fariss, R. N., Rodriguez, I. R., & Wong, W. T. (2015) · Scientific Reports · doi:10.1038/srep09144 · Cited by 101
Kyosseva, S. V., Chen, L., Seal, S., & McGinnis, J. F. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.08.003 · Cited by 82
RETINAL ANGIOMATOUS PROLIFERATION: Natural History and Progression of Visual Loss
VIOLA, F., MASSACESI, A., ORZALESI, N., RATIGLIA, R., & STAURENGHI, G. (2009) · Retina · doi:10.1097/iae.0b013e3181a395cb · Cited by 79
AAV8-antiVEGFfab Ocular Gene Transfer for Neovascular Age-Related Macular Degeneration
Liu, Y., Fortmann, S. D., Shen, J., Wielechowski, E., Tretiakova, A., Yoo, S., Kozarsky, K., Wang, J., Wilson, J. M., & Campochiaro, P. A. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2017.12.002 · Cited by 51
“These mice provide a model for retinal angiomatous proliferation, also known as type 3 choroidalNV in humans.(24) After subretinal injection of PBS at P14, retinas of rho/VEGFmice stainedwith fluorescein isothiocyanate (FITC)-labeledGriffonia simplicifolia (GSA) lectin, which selectively stains vascular cells, were fl…”
BackgroundRouvas, A. A., Chatziralli, I. P., Theodossiadis, P. G., Moschos, M. M., Kotsolis, A. I., & Ladas, I. D. (2012) · Retina · doi:10.1097/iae.0b013e318235d8ce · Cited by 30
“Retinal angiomatous proliferation accounts for 10% to 15% of all neovascular age-related macular degeneration in white patients and 4.5% in Japanese patients,2,3 but its natural course is believed to be worse 1181 than that of typical exudative age-related macular degeneration; therefore, its recognition is essential.…”
BackgroundInfluential
Metadata
- Authors
- Yannuzzi, L. A., Negrão, S., IIDA, T., Carvalho, C., Rodriguez-Coleman, H., Slakter, J., Freund, K. B., Sorenson, J., Orlock, D., & Borodoker, N.
- Venue
- Retina
- Published
- 2012-02
- Volume
- 32
- Issue
- Supplement 1
- Pages
- 416-434
- ISSN
- 0275-004X (ISSN-L)
- OpenAlex
- W1998386860
- Cited by
- 660
- References
- 35
- FWCI
- 36.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.